STELARA® induced clinical response and remission in phase 3 study for the treatment of patients with moderate to severe Crohn’s disease who had previously failed or were intolerant to anti-tnf-alpha therapy
- EMEA Innovative Medicine
- STELARA® induced clinical response and remission in phase 3 study for the treatment of patients with moderate to severe Crohn’s disease who had previously failed or were intolerant to anti-tnf-alpha therapy
STELARA® induced clinical response and remission in phase 3 study for the treatment of patients with moderate to severe Crohn’s disease who had previously failed or were intolerant to anti-tnf-alpha therapy
- X (Twitter)
Copy link